Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
J Neuroendocrinol ; 21(10): 813-21, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19678868

ABSTRACT

Pulsatile release of gonadotrophin-releasing hormone (GnRH) is indispensable to maintain normal gonadotrophin secretion. The pulsatile secretion of GnRH is associated with synchronised electrical activity in the mediobasal hypothalamus (i.e. multiple unit activity; MUA), which is considered to reflect the rhythmic oscillations in the activity of the neuronal network that drives pulsatile GnRH secretion. However, the cellular source of this ultradian rhythm in GnRH activity is unknown. Direct input from kisspeptin neurones in the arcuate nucleus (ARC) to GnRH cell bodies in the medial preoptic area or their terminals in the median eminence could be the intrinsic source for driving the GnRH pulse generator. To determine whether kisspeptin signalling could be responsible for producing pulsatile GnRH secretion, we studied goats, measured plasma levels of luteinising hormone (LH) and recorded MUA in the posterior ARC, where the majority of kisspeptin neuronal cell bodies are located. Rhythmic volleys of MUA were found to be accompanied by LH pulses with regular intervals in the ARC, where kisspeptin neuronal cell bodies were found. Exogenous administration of kisspeptin stimulated a sustained increase in LH secretion, without influencing MUA, suggesting that the GnRH pulse generator, as reflected by MUA, originated from outside of the network of GnRH neurones, and could plausibly reflect the pacemaker activity of kisspeptin neurones, whose projections reach the median eminence where GnRH fibres project. These observations suggest that the kisspeptin neurones in the ARC may be the intrinsic source of the GnRH pulse generator.


Subject(s)
Arcuate Nucleus of Hypothalamus/physiology , Gonadotropin-Releasing Hormone/metabolism , Hypothalamus/physiology , Neurons/physiology , Periodicity , Amino Acid Sequence , Animals , Electrodes, Implanted , Goats , Humans , Immunohistochemistry , In Situ Hybridization , Kisspeptins , Luteinizing Hormone/blood , Male , Molecular Sequence Data , Neural Pathways/physiology , Orchiectomy , Sequence Homology, Amino Acid , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
2.
Anim Reprod Sci ; 106(3-4): 361-8, 2008 Jul.
Article in English | MEDLINE | ID: mdl-17573212

ABSTRACT

In the sheep and goat, exposure of anestrous females to a conspecific male odor enhances reproductive activity. Interestingly, a previous report indicated that male goat hair stimulated pulsatile luteinizing hormone (LH) secretion in the ewe. In the present study, we addressed whether ram wool affects the gonadotropin-releasing hormone (GnRH) pulse generator activity in the female goat. Five ovariectomized (OVX) goats were chronically implanted with recording electrodes in the mediobasal hypothalamus, and manifestations of the GnRH pulse generator were monitored as characteristic increases in multiple-unit activity (MUA volleys). Wool or hair samples were collected from a mature ram, ewe and male goat, and their effects on the MUA volley were examined. The exposure to ram wool induced an MUA volley within 1 min in all five OVX goats, as did the exposure to male goat hair. The ewe wool had no effect on the timing of an MUA volley occurrence. An invariable association of MUA volleys with LH pulses in the peripheral circulation was also confirmed in two OVX goats exposed to ram wool. The present results clearly indicate that exposure to ram wool stimulates pulsatile GnRH/LH release in the female goat. Since exposure to male goat hair enhances pulsatile LH secretion in the ewe, it is likely that very similar, if not identical, molecules are contained in the male-effect pheromone in the sheep and goat.


Subject(s)
Goats/blood , Gonadotropin-Releasing Hormone/blood , Sheep/physiology , Wool/physiology , Animals , Female , Goats/physiology , Hair/physiology , Luteinizing Hormone/blood , Male , Pulsatile Flow , Sex Factors
3.
Eur Respir J ; 26(5): 795-803, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16264039

ABSTRACT

The exacerbation of asthma during viral infections is mainly explained by neutrophils infiltrating into the airways. However, enhanced functions of eosinophils are also observed. The aim of this study was to reveal the mechanism of how eosinophils are activated during and after viral infection of the airways, using a model of viral infection. A synthetic double-stranded RNA, poly inosinic-cytidyric acid (poly(IC)), was transfected to a human airway epithelial cell line (BEAS-2B) and the primary bronchial epithelial cells, to mimic a viral infection. The production of chemokines from the cells was investigated. The transfection of poly(IC), alone, marginally affected the eotaxin-3 production of the cells. However, the transfection of poly(IC) prior to interleukin (IL)-4 stimulation enhanced eotaxin-3 production. Poly(IC) transfection increased mRNA and protein expressions of IL-4 receptor (R)alpha and IL-2Rgamma, components of the IL-4R. In BEAS-2B cells, IL-4-mediated phosphorylation of signal transducer and activator of transcription six was enhanced in poly(IC) transfected cells. This was reversed by the addition of anti-IL-4Ralpha antibody, suggesting the role of an increased number of IL-4 receptors in enhanced IL-4-induced eotaxin-3 production. Poly(IC)-induced upregulation of IL-4Ralpha was inhibited by treatment with cycloheximide or dexamethasone. In conclusion, these results suggest that viral airway infection may enhance interleukin-4-induced eotaxin-3 production through upregulation of the interleukin-4 receptor in airway epithelial cells.


Subject(s)
Chemokines, CC/metabolism , Epithelial Cells/metabolism , Receptors, Interleukin-4/metabolism , Respiratory Mucosa/metabolism , Respiratory Tract Infections/metabolism , Virus Diseases/metabolism , Cells, Cultured , Chemokine CCL26 , Chemokines, CC/genetics , Humans , RNA, Double-Stranded/genetics , Respiratory Tract Infections/complications , Transfection/methods , Up-Regulation , Virus Diseases/complications
4.
J Neuroendocrinol ; 15(1): 80-6, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12535173

ABSTRACT

To clarify central actions of cholecystokinin-octapeptide (CCK-8) on reproduction, effects of an intracerebroventricular (i.c.v.) administration of CCK-8 on the activity of the gonadotropin-releasing hormone (GnRH) pulse generator were examined in ovariectomized (OVX) goats in the absence or presence of oestradiol. Goats were chronically fitted with recording electrodes in the mediobasal hypothalamus, and electrophysiological manifestations of the GnRH pulse generator were monitored as characteristic increases in the multiple-unit activity (MUA volleys). In OVX goats, a bolus i.c.v. injection of as little as 0.01 nmol of CCK-8 induced a MUA volley with a short latency, which resulted in a significant decrease in the post-treatment volley interval compared to that in the saline injected control. Administration of higher doses of CCK-8 (0.1 and 2 nmol) did not further accelerate the occurrence of the MUA volley, but stimulatory effects were observed for a longer period than that after the 0.01 nmol injection. When goats were treated with oestradiol, while a bolus i.c.v. injection of 0.01 nmol CCK-8 had no effect, an injection of 0.1 nmol of the peptide significantly decreased the post-treatment volley interval. On continuous i.c.v. infusion of CCK-8 at 3 nmol per 200 micro l/h for 3 h, MUA volleys with shorter intervals than those in the control were successively induced without any apparent change in basal plasma luteinizing hormone levels in OVX goats. These results demonstrate that central CCK-8 strongly accelerates the activity of the GnRH pulse generator in goats.


Subject(s)
Appetite Depressants/pharmacology , Gonadotropin-Releasing Hormone/metabolism , Hypothalamo-Hypophyseal System/metabolism , Pituitary-Adrenal System/metabolism , Sincalide/pharmacology , Animals , Eating/drug effects , Goats , Hydrocortisone/blood , Hypothalamo-Hypophyseal System/drug effects , Injections, Intraventricular , Pituitary-Adrenal System/drug effects , Pulsatile Flow , Satiation/drug effects
5.
Endocrinology ; 142(6): 2489-98, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11356698

ABSTRACT

To understand central mechanisms for nutritional infertility, the activity of the GnRH pulse generator was directly assessed in ovariectomized (OVX) goats under several experimental conditions by recording characteristic increases in the multiple-unit activity (volleys). When estradiol (E(2))-treated animals were fasted for 4-5 days, the activity of the GnRH pulse generator was gradually suppressed, and the volley interval at the end of fasting was significantly prolonged, compared with that during the feeding period (67.4 vs. 49.3 min, n = 5, P < 0.01). On the other hand, such a significant effect on the pulse generator was not observed in OVX goats. In the second experiment, the animals received a bolus intracerebroventricular injection of several doses (0, 2, 5, and 20 microg/400 microl) of neuropeptide Y (NPY). Exogenous NPY dose-dependently inhibited the pulse generator activity. At the highest dosage, the 1st posttreatment volley interval was significantly longer than that of the pretreatment (112.4 vs. 32.6 min, n = 5, P < 0.01) in OVX goats. The suppressive effect of NPY was similarly observed in OVX+E(2) goats. Further, when NPY was infused (10 microg/200 microl.h for 6 h) into OVX goats, the activity of the GnRH pulse generator was almost completely inhibited during the infusion period. Hypothalamic sites responding to fasting were immunohistochemically evaluated using an antibody for Fos in castrated goats. Fos-immunoreactive neurons were found in areas adjacent to the third ventricle. Double-labeling immunohistochemistry revealed that a subpopulation of NPY neurons in the arcuate nucleus was activated in response to fasting. These results demonstrate that: 1) the activity of the GnRH pulse generator is suppressed by fasting in the presence of E(2); 2) exogenous NPY inhibits the activity of the GnRH pulse generator regardless of the presence of E(2); and 3) several hypothalamic neurons or regions, including those containing NPY in the arcuate nucleus, are activated by fasting. Collectively, these observations suggest that NPY acts as a mediator of undernutrition to the GnRH pulse generator.


Subject(s)
Animal Nutritional Physiological Phenomena , Goats/physiology , Gonadotropin-Releasing Hormone/metabolism , Hypothalamus/physiology , Neuropeptide Y/physiology , Animals , Arcuate Nucleus of Hypothalamus/chemistry , Electrophysiology , Estradiol/pharmacology , Fasting , Female , Hypothalamus/chemistry , Hypothalamus/drug effects , Immunohistochemistry , Injections, Intraventricular , Neurons/chemistry , Neuropeptide Y/administration & dosage , Ovariectomy , Proto-Oncogene Proteins c-fos/analysis
7.
Blood ; 96(2): 601-9, 2000 Jul 15.
Article in English | MEDLINE | ID: mdl-10887124

ABSTRACT

Interleukin (IL)-4, IL-10, and IL-13, Th2 cell-derived cytokines, play major roles in the pathophysiology of allergic diseases. These cytokines up-regulate or down-regulate the production of arachidonic acid metabolites. In this study, we have investigated the effect of IL-4, IL-10, IL-13, and other cytokines on A23187-stimulated synthesis of leukotriene (LT) B(4) in human polymorphonuclear leukocytes (PMNs). Production of LTB(4) was measured by specific radioimmunoassay and high performance liquid chromatography. Messenger RNA (mRNA) expression of cytosolic phospholipase A(2) (cPLA(2)), 5-lipoxygenase (5-LO), and LTA(4) hydrolase, which were involved in the synthesis of LTB(4), was determined by reverse transcription-polymerase chain reaction and Northern blot analysis. Protein synthesis of their enzymes was determined by Western blot analysis. IL-4 and IL-13 enhanced A23187-stimulated LTB(4) synthesis and increased mRNA expression and protein synthesis of LTA(4) hydrolase, but not those of cPLA(2) or 5-LO. These results indicate that IL-4 and IL-13 transcriptionally or post-transcriptionally up-regulate the synthesis of LTB(4), a potent chemotactic factor to PMNs, at the enzyme level of LTA(4) hydrolase, and this up-regulation mechanism may participate in the development of allergic inflammation. (Blood. 2000;96:601-609)


Subject(s)
Epoxide Hydrolases/biosynthesis , Interleukin-13/pharmacology , Interleukin-4/pharmacology , Neutrophils/enzymology , Arachidonate 5-Lipoxygenase/genetics , Blotting, Northern , Blotting, Western , Calcimycin/pharmacology , Chromatography, High Pressure Liquid , Enzyme Induction , Epoxide Hydrolases/genetics , Humans , Interleukin-10/pharmacology , Ionophores/pharmacology , Leukotriene B4/biosynthesis , Phospholipases A/genetics , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction
8.
Int J Immunopharmacol ; 22(7): 483-90, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10785545

ABSTRACT

AS-35, (9-[4-acetyl-3-hydroxy-2-n-propylphenoxy) methyl]-3-(1H-tetrazol-5-yl)-4H-pyrido[1, 2-a] pyrimidin-4-one), was developed as a leukotriene (LT) receptor antagonist, which also inhibited IgE-mediated release of leukotrienes (LTs). We have investigated the action of AS-35 on the enzyme activities which are involved in the synthesis of LTC(4) and LTB(4) (LT-synthesizing enzymes); cytosolic phospholipase A(2) (cPLA(2)), 5-lipoxygenase (5-LO), leukotriene (LT)C(4) synthase and LTA(4) hydrolase. AS-35 dose-dependently inhibited IgE- and A23187-stimulated production of LTC(4) by up to 71.5-84.8% and that of LTB(4) by 48.3-49.2% at 2. 5x10(-5) M. The assays for cPLA(2)(-), 5-LO-, LTC(4) synthase- and LTA(4) hydrolase-activities revealed that the inhibition is attributable to suppression of cPLA(2), 5-LO and LTC(4) synthase but not LTA(4) hydrolase. We have also studied the action of AS-35 on the release of beta-hexosaminidase (beta-HEX) as a marker of preformed mediators. AS-35 had only weak inhibitory action on the release of beta-HEX. The results indicate that anti-allergic action of AS-35 is predominantly attributable to its inhibition of LT synthesis by suppressing three consecutive enzymes for LTC(4) synthesis.


Subject(s)
Leukotriene Antagonists/pharmacology , Leukotriene B4/antagonists & inhibitors , Leukotriene B4/biosynthesis , Leukotriene C4/antagonists & inhibitors , Leukotriene C4/biosynthesis , Pyridines/pharmacology , Pyrimidinones/pharmacology , Tetrazoles/pharmacology , Animals , Arachidonic Acid/metabolism , Cell-Free System , Cytosol/enzymology , Leukotriene A4/metabolism , Phospholipases A/metabolism , Rats , Substrate Specificity , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/enzymology , Tumor Cells, Cultured/metabolism , beta-N-Acetylhexosaminidases/metabolism
9.
J Infect Dis ; 181(3): 1101-9, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10720537

ABSTRACT

Kawasaki disease is an inflammatory disease of unknown cause that causes panvasculitis, including coronary arteritis. Polymorphonucleocytosis in the early stage of the illness suggests the implication of neutrophils in the pathogenesis of the disease. In the acute phase of Kawasaki disease, mRNA expression of prostaglandin H2 synthase (PHS)-2, as determined by reverse transcription-polymerase chain reaction, was markedly enhanced, and thromboxane A2 (TXA2)-synthesizing activity was increased in polymorphonuclear leukocytes (PMNL). This up-regulation of PHS-2 was suppressed by ulinastatin (a neutrophil-elastase inhibitor) treatment. Lipopolysaccharide-induced enhancement of PHS-2 mRNA was also inhibited by therapeutic doses of ulinastatin in vitro by use of PMNL from healthy volunteers. Thus, ulinastatin inhibits arachidonate PHS metabolism by inhibiting new induction of PHS-2 at the mRNA level, which is a novel pharmacologic action of this substance. Ulinastatin treatment is possibly an additional therapeutic approach to Kawasaki disease.


Subject(s)
Glycoproteins/pharmacology , Isoenzymes/genetics , Mucocutaneous Lymph Node Syndrome/drug therapy , Pancreatic Elastase/antagonists & inhibitors , Prostaglandin-Endoperoxide Synthases/genetics , RNA, Messenger/analysis , Aspirin/pharmacology , Child , Child, Preschool , Female , Humans , Lipopolysaccharides/pharmacology , Male , Mucocutaneous Lymph Node Syndrome/metabolism , Neutrophils/metabolism , Phospholipases A/genetics , Thromboxane B2/biosynthesis , Thromboxane-A Synthase/genetics
10.
Int Surg ; 85(4): 277-80, 2000.
Article in English | MEDLINE | ID: mdl-11589591

ABSTRACT

AIM: We examined the indication of upper mediastinal lymphadenectomy for a squamous cell carcinoma of the lower thoracic oesophagus. METHODS: 49 patients underwent a curative oesophagectomy with upper mediastinal lymphadenectomy for a squamous cell carcinoma of the lower thoracic oesophagus. Node status and clinicopathological characteristics of these patients were reviewed retrospectively. RESULTS: 16 (94.1%) of 17 patients with superficial tumours had no positive node in the upper mediastinum. Nine (29.0%) of 31 patients with transmural tumours had positive nodes in the upper mediastinum (P = 0.04). Ten (20.4%) of 49 patients had many positive nodes in the upper mediastinum. Of these 10 patients, 6 patients had 5 or more positive nodes in all. The 5-year survival rate for patients with 5 or more positive nodes was 7.7%, which was significantly poorer than patients with 4 or fewer positive nodes. CONCLUSIONS: Upper mediastinal lymphadenectomy is unnecessary in most of the superficial squamous carcinomas of the lower thoracic oesophagus.


Subject(s)
Carcinoma, Squamous Cell/surgery , Esophageal Neoplasms/surgery , Lymph Node Excision/methods , Lymph Nodes/pathology , Lymph Nodes/surgery , Aged , Aged, 80 and over , Biopsy, Needle , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Female , Follow-Up Studies , Humans , Lymphatic Metastasis , Male , Mediastinum , Middle Aged , Neoplasm Staging , Probability , Retrospective Studies , Survival Rate , Treatment Outcome
11.
Eur J Haematol ; 63(2): 94-102, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10480288

ABSTRACT

Polymorphonuclear leukocytes (PMNs) produce arachidonic acid (AA) metabolites including thromboxane A2 (TXA2). These cells are the first line of defense against bacterial invasion, which often causes endotoxin shock. TXA2 which plays an important role in the pathogenesis of endotoxin shock is synthesized by three consecutive enzyme activation, cytosolic phospholipase A2 (cPLA2), prostaglandin H2 synthase (PHS type 1 and type 2) and TXA2 synthase. Among them, cPLA2- and PHS-2 activity is known to be transcriptionally and/or posttranscriptionally up-regulated by various bioactive substances including lipopolysaccharide (LPS), a bacterial endotoxin, in many cell types. We investigated the action of LPS on TXA2 synthesis in human PMNs. A23187-stimulated production of thromboxane B2 (TXB2, a stable metabolite of TXA2), assayed by specific radioimmunoassay (RIA), was significantly increased from 566.7+/-44.1 pg/10(6) cells to 966.7+/-44.1 pg/10(6) cells (p<0.05) after 6 h-exposure to LPS at the concentration of 100 ng/ml. Messenger RNA for PHS-2, PHS-1, TXA2 synthase and cPLA2, which was assessed by reverse transcription-polymerase chain reaction (RT-PCR), was expressed in PMNs without LPS stimulation. Although PHS-2 was putatively an inducible enzyme, abundance of mRNA for PHS-2 in PMNs without LPS stimulation was detectable. Messenger RNA abundance for PHS-2 and cPLA2, but not for PHS-1 and TXA2 synthase, was enhanced by LPS-treatment, indicating that the increased production of TXB2 was attributable to the up-regulation of cPLA2 and PHS-2. We conclude that (1) PHS-2 plays a more important role than PHS-1 in the production of TXA2 in human PMNs and (2) TXA2 synthesis in human PMNs is transcriptionally up-regulated by new induction of cPLA2 as well as PHS-2, when the cells encounter endotoxin producing bacteria.


Subject(s)
Isoenzymes/biosynthesis , Lipopolysaccharides/pharmacology , Neutrophils/drug effects , Phospholipases A/biosynthesis , Prostaglandin-Endoperoxide Synthases/biosynthesis , Aspirin/pharmacology , Calcimycin/pharmacology , Cyclooxygenase 1 , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/pharmacology , Enzyme Induction/drug effects , Group IV Phospholipases A2 , Humans , Isoenzymes/genetics , Membrane Proteins , Neutrophils/enzymology , Nitrobenzenes/pharmacology , Phospholipases A/genetics , Phospholipases A2 , Prostaglandin-Endoperoxide Synthases/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sulfonamides/pharmacology , Thromboxane B2/biosynthesis , Thromboxane-A Synthase/biosynthesis , Thromboxane-A Synthase/genetics
12.
Planta Med ; 65(3): 222-6, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10232065

ABSTRACT

We have observed an inhibitory action of magnolol on the production of leukotriene (LT) C4 and LTB4, important lipid mediators in allergy and inflammation. IgE- and A23187-stimulated production of LTC4 and LTB4 was measured by radio-immunoassay (RIA) in the absence or presence of various concentrations of magnolol in intact rat basophilic leukemia (RBL)-2H3 cells. Magnolol dose-dependently inhibited synthesis of LTC4 and LTB4. Magnolol inhibited the IgE-mediated increase of intracellular calcium ion concentration, resulting in the inhibition of cytosolic phospholipase A2 (cPLA2) and possibly 5-lipoxygenase (5-LO), both calcium ion-dependent enzymes. In cell-free studies magnolol inhibited LTC4 synthase activity. LTA4 hydrolase activity was only inhibited at the higher concentration (2.5 x 10(-5)M). These results indicate that magnolol inhibits production of LTs by inhibiting PLA2, 5-LO, LTC4 synthase and LTA4 hydrolase which are essential for LT-synthesis. Magnolol may have anti-allergic effect by blocking LT-synthesis.


Subject(s)
Biphenyl Compounds/pharmacology , Leukemia, Basophilic, Acute/metabolism , Leukotriene B4/biosynthesis , Leukotriene C4/biosynthesis , Lignans , Animals , Enzyme Inhibitors/pharmacology , Epoxide Hydrolases/antagonists & inhibitors , Glutathione Transferase/antagonists & inhibitors , Leukemia, Basophilic, Acute/enzymology , Leukemia, Basophilic, Acute/pathology , Lipoxygenase Inhibitors , Rats , Tumor Cells, Cultured
13.
J Asthma ; 35(5): 445-8, 1998.
Article in English | MEDLINE | ID: mdl-9734352

ABSTRACT

There are substantial numbers of reports showing that leukotrienes (LTs) play important roles in adult asthma. No definite evidence has been demonstrated that LTs are involved in asthma attacks in children, although it is highly expected. In this report, we demonstrated that the levels of LTB4 and LTC4 but not thromboxane B2 (TXB2), a stable metabolite of TXA2, were significantly elevated in the bronchoalveolar lavage fluid, which was obtained from intubated and mechanically ventilated children with severe asthma attacks. This is direct evidence that LTB4 and LTC4 predominantly participate in asthma attacks in pediatric patients.


Subject(s)
Asthma/physiopathology , Leukotriene B4/physiology , Leukotriene C4/physiology , Thromboxane A2/physiology , Adolescent , Child, Preschool , Female , Humans , Male
14.
Article in English | MEDLINE | ID: mdl-9654399

ABSTRACT

To determine the inhibitory mechanisms of terfenadine on the synthesis of leukotriene C4 (LTC4), an important mediator in allergic diseases, we evaluated the action of terfenadine on the IgE-dependent production of LTC4 in rat basophilic leukaemia 2H3 cells. Rat IgE-loaded cells were stimulated with anti-IgE in the presence or absence of various concentrations of terfenadine and the level of LTC4 released into the medium was measured by performing a specific radio immunoassay. Terfenadine inhibited the synthesis of LTC4 to 67.2% at a concentration of 5 microg/ml. LT synthesis was directly suppressed by inhibition of 5-lipoxygenase (5-LO) through calcium ion-independent mechanisms, and was also possibly suppressed by inhibition of cytosolic phospholipase A2 and 5-LO by blocking the influx of intracellular calcium ion that was initiated by IgE-related stimulation.


Subject(s)
Anti-Allergic Agents/pharmacology , Leukotriene Antagonists , Leukotrienes/biosynthesis , Terfenadine/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Antibodies, Anti-Idiotypic/pharmacology , Arachidonic Acid/metabolism , Calcimycin/pharmacology , Calcium/metabolism , Immunoglobulin E/immunology , Immunoglobulin E/pharmacology , Leukotriene A4/metabolism , Leukotriene B4/biosynthesis , Leukotriene B4/metabolism , Leukotriene C4/biosynthesis , Leukotriene C4/metabolism , Substrate Specificity , Tritium , Tumor Cells, Cultured/cytology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism
15.
Article in English | MEDLINE | ID: mdl-10102384

ABSTRACT

Human leukemia (HL) 60 cells were differentiated by dimethylsulfoxide (DMSO) treatment to granulocyte-like cells, leukotriene (LT) synthesizing activity of which was increased in response to the differentiation of the cells. Four synthesizing enzymes, cytosolic phospholipase A2 (cPLA2), 5-lipoxygenase (5-LO), LTA4 hydrolase and LTC4 synthase, and an enzyme associated protein, 5-lipoxygenase activating protein (FLAP) are involved in the generation of LTC4 and LTB4. We examined the expression of messenger RNA (mRNA) for these LT synthesizing enzymes and an associated protein in DMSO differentiated HL-60 cells by reverse transcriptase polymerase chain reaction (RT-PCR). The production of LTC4 and LTB4, measured by radioimmunoassay (RIA), was increased after the incubation with DMSO for more than 3 days. Messenger RNA abundance for 5-LO, LTC4 synthase and LTA4 hydrolase was increased, that for FLAP was stable, but that for cPLA2 was decreased. These results indicate that DMSO induced increase of LT synthesis is associated with the increase of mRNA expression of 5-LO, LTC4 synthase and LTA4 hydrolase, although the precise regulatory mechanisms of the increased mRNA expression are not determined. We also investigated an action of dexamethasone (DEX) on DMSO-induced enhancement of LT synthesis. DEX suppressed DMSO induced increase of LTC4 synthesis, but rather enhanced DMSO induced LTB4 production. The DEX attenuated the DMSO-induced increase of mRNA expression for LTC4 synthase, but showed no effect on that for LTA4 hydrolase. The inhibition of LTC4 synthesis is associated with the suppression of mRNA expression for LTC4 synthase. However, increased LTB4 synthesis by DEX is regulated by the mechanisms which are independent from mRNA level of LTA4 hydrolase.


Subject(s)
Dexamethasone/pharmacology , Dimethyl Sulfoxide/pharmacology , Leukotrienes/biosynthesis , 5-Lipoxygenase-Activating Proteins , Arachidonate 5-Lipoxygenase/metabolism , Carrier Proteins/metabolism , Dose-Response Relationship, Drug , HL-60 Cells , Humans , Leukotriene A4/metabolism , Leukotriene C4/metabolism , Membrane Proteins/metabolism , Phospholipases A/metabolism , Phospholipases A2 , Reverse Transcriptase Polymerase Chain Reaction , Superoxide Dismutase/metabolism , Time Factors
16.
Dent Mater J ; 17(4): 294-300, 1998 Dec.
Article in English | MEDLINE | ID: mdl-10219143

ABSTRACT

To clarify the factors determining the dimensional stability of alginate impressions during immersion in disinfectant and fixing solution, the weight change of impressions in solutions of glutaraldehyde (GA), NaClO, Na2SO4, K2SO4, CaCl2, and ZnSO4 was measured. In the nonelectrolytic solution, GA, the weight decreased in proportion to concentration, possibly due to the gradient of osmotic pressure between the impression and solution. In monovalent metallic salt solutions the weight change decreased with increased concentration. Especially at lower concentrations the rate of weight loss was high. A chemical action of the solution might also be involved, in addition to the osmotic pressure difference. The weight loss in divalent metallic salt solutions was greater than in monovalent solutions, implicating crosslinking reactions between the impression and solution.


Subject(s)
Alginates/chemistry , Dental Disinfectants/chemistry , Dental Impression Materials/chemistry , Calcium Chloride/chemistry , Gels , Glutaral/chemistry , Osmolar Concentration , Sodium Hypochlorite/chemistry , Solutions/chemistry , Sulfates/chemistry , Viscosity , Zinc Sulfate/chemistry
17.
Ann Allergy Asthma Immunol ; 78(5): 517-23, 1997 May.
Article in English | MEDLINE | ID: mdl-9164367

ABSTRACT

BACKGROUND: Cytokines, such as interleukin (IL)-5, produced by T helper type 2 Th2) cells appear to play an important role in the inflammatory processes associated with atopic dermatitis. The roles of cytokines produced by Th1 cells remain controversial. OBJECTIVE: We examined IL-5 and IL-2 mRNA abundance in and protein production by peripheral blood mononuclear cells (PBMCs) from patients with atopic dermatitis and compared those from controls. METHODS: Peripheral blood mononuclear cells were isolated from six children with atopic dermatitis and six control children, and stimulated with both phytohemaggulutinin (PHA) and phorbol 12-myristate 13-acetate (PMA). The abundance of IL-5 and IL-2 mRNA in PBMCs was measured by reverse transcription-polymerase chain reaction analysis. The production of IL-5 and IL-2 by PBMCs was also determined by enzyme-linked immunosorbent assay. RESULTS: After incubation with PHA and PMA, PBMCs from atopic children showed significantly higher IL-5 mRNA abundance (P < .05) and IL-5 production (P < .01), as well as a lower amount of IL-2 mRNA (P = .056) and IL-2 production (P < .05) than those from healthy controls. The time course of changes in IL-5 mRNA abundance induced by PHA and PMA in PBMCs from atopic children differed markedly from that observed with healthy controls, whereas the time course of changes in IL-2 mRNA abundance were similar between the two groups. CONCLUSIONS: The increased IL-5 and decreased IL-2 production observed with PBMCs from children with atopic dermatitis may underlie the activation of eosinophils and high serum immunoglobulin E concentrations also apparent in such individuals. An imbalance in the number and activity of Th1 and Th2 cells is likely to be responsible for the abnormal pattern of cytokine production in atopic dermatitis.


Subject(s)
Dermatitis, Atopic/metabolism , Interleukin-2/metabolism , Interleukin-5/metabolism , Adolescent , Child , Child, Preschool , Cytokines/genetics , Dermatitis, Atopic/blood , Female , Humans , Leukocytes, Mononuclear/metabolism , Male , Polymerase Chain Reaction , RNA, Messenger/metabolism
18.
J Ethnopharmacol ; 56(2): 123-31, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9174973

ABSTRACT

We examined the action of Shinpi-To (Formula divinita; TJ-85), a granular extract of seven Chinese medicinal herbs that is used in treating childhood asthma, on the leukotriene synthesis in rat basophilic leukemia-2H3 cells (RBL-2H3 cells). IgE-loaded cells were stimulated with anti-IgE serum in the presence or absence of Shinpi-To. Released LTC4 and LTB4 were measured by radioimmunoassay (RIA). Shinpi-To significantly inhibited IgE-mediated synthesis of leukotriene (LT)C4 and LTB4. To identify the inhibitory sites, we investigated the action of this extract on four synthetic enzymes, phospholipase A2 (PLA2), 5-lipoxygenase (5-LO). LTC4 synthase, and LTA4 hydrolase. Shinpi-To inhibited the A23187-stimulated release of [3H]arachidonic acid (AA) from the cell membrane, reflecting an effect on PLA2 activity. It also suppressed production of LTC4 and LTB4 when cell lysates were incubated with AA as substrate. It did not inhibit the production of LTC4 and LTB4 when LTA4-free acid was used as the substrate. Shinpi-To did not inhibit the IgE-mediated increase of intracellular Ca2+ ([Ca2+]i) concentration. Results indicate that Shinpi-To inhibits LT synthesis by inhibiting PLA2 and 5-LO activities without affecting the mobilization of [Ca2+]i.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Immunoglobulin E/immunology , Leukotriene B4/biosynthesis , Leukotriene C4/biosynthesis , Analysis of Variance , Animals , Arachidonic Acid/metabolism , Asthma/drug therapy , Bronchodilator Agents/pharmacology , Calcimycin/toxicity , Calcium/metabolism , Cell Membrane/drug effects , Cell Membrane/metabolism , Drugs, Chinese Herbal/therapeutic use , Ephedrine/analogs & derivatives , Ephedrine/pharmacology , Ionophores/toxicity , Isotope Labeling , Leukemia, Basophilic, Acute/pathology , Leukotriene A4/biosynthesis , Leukotriene B4/metabolism , Leukotriene C4/metabolism , Lipoxygenase Inhibitors/pharmacology , Phospholipases A/antagonists & inhibitors , Phospholipases A2 , Radioimmunoassay , Rats , Tritium , Tumor Cells, Cultured
19.
Gastroenterology ; 111(3): 778-82, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8780585

ABSTRACT

An extremely rare case of primary gastrointestinal T-cell lymphoma involving the stomach and intestine is reported. Radiographic and endoscopic examinations showed multiple polypoid lesions covered by a normal-appearing mucosa in the stomach, duodenal bulb, and terminal ileum and numerous small aphthoid lesions throughout the entire colorectum. Histopathologic, immunohistochemical, and polymerase chain reaction studies were performed using paraffin-embedded or fresh-frozen specimens from endoscopic biopsies and endoscopic mucosal resections. All lesions were composed of small, atypical lymphoid cells, which were classified as low-grade pleomorphic lymphoma. The tumor cells expressed CD3, CD4, and the T-cell receptor gamma gene phenotype as well as human mucosal lymphocyte 1 antigen, suggesting that the lymphoma cells were derived from intraepithelial T lymphocytes. This is the first description of primary gastrointestinal T-cell lymphoma with expression of human mucosal lymphocyte 1 antigen and a novel morphology resembling multiple lymphomatous polyposis.


Subject(s)
Gastrointestinal Neoplasms/pathology , Lymphoma, T-Cell/pathology , Lymphoma/pathology , Polyps/pathology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Colon/diagnostic imaging , Colon/pathology , Gastrointestinal Neoplasms/drug therapy , Gastrointestinal Neoplasms/metabolism , Humans , Immunohistochemistry , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/metabolism , Male , Middle Aged , Polymerase Chain Reaction , Radiography , Stomach/pathology
20.
Int Arch Allergy Immunol ; 110(3): 278-81, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8688675

ABSTRACT

The effects of honokiol, a diphenyl compound extracted from a Chinese herbal medicine, on leukotriene (LT) synthesis were evaluated in rat basophilic leukemia (RBL) cells. The production of LTC4 and LTB4 stimulated by the Ca2+ ionophore A23187 was measured in RBL-1 cells by high-performance liquid chromatography. Honokiol inhibited the production of LTC4 and LTB4 stimulated by A23187 in RBL-1 cells. Honokiol did not inhibit either phospholipase A2 activity, measured by the release of 3H-arachidonic acid (AA), or LTC4 synthase and LTA4 hydrolase activities, measured with LTA4-free acid as substrate. The synthesis of LTC4 and LTB4 from AA in RBL-1 cell lysates in the presence of Ca2+ was inhibited by honokiol. These results indicate that honokiol blocks LT synthesis by inhibiting 5-lipoxygenase activity. Honokiol also inhibited immunoglobulin E-mediated production of these LTs in RBL-2H3 cells, which was measured by a specific radioimmunoassay (RIA). These results suggest that honokiol may exhibit antiallergic actions by inhibiting LT synthesis in immediate-type hyperreactivity.


Subject(s)
Anti-Allergic Agents/pharmacology , Biphenyl Compounds/pharmacology , Leukemia, Basophilic, Acute/metabolism , Leukotriene Antagonists , Leukotrienes/biosynthesis , Lignans , Animals , Leukemia, Basophilic, Acute/enzymology , Rats , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...